Newsletter

Impact of Brexit on Pharma Space
How the exit of UK has impacted the pharma and healthcare market in the UK and overall

Impact of Brexit on Pharma Space


The Union of the European countries, also known as the European Union or the EU, is more or less like a conglomerate of countries. These countries make up the whole continent. The economic and political ties that EU countries share were fostered after the end of World War II. Since then, the EU has been considered as a single market. This was taken in a positive light, but lately, this forced camaraderie had come under the scanner when Britain voted to leave the Union.

BREXIT, the ‘EXIT’ of ‘BRITAIN’ from ‘EUROPEAN UNION’, shook the whole world when the United Kingdom voted in favour of leaving the EU.

The provision of BREXIT was carried out by the European Union Referendum Act 2015 (c 36), which is an Act of the Parliament of the UK. This referendum was created to provide a legal provision for the United Kingdom of Great Britain and Northern Ireland and Gibraltar to choose to remain or leave the membership of the European Union.

The whitepaper covers the Journey right from the EU referendum and the need for Brexit listing Implications of the Brexit on the pharma market in different regions, Economic consequences in the UK. The most significant uncertainty the pharmaceutical industry is facing if the UK were to leave the EU is the impact on regulatory processes and market authorisation of drugs in the UK.

Inside the Report:

More Whitepapers / Newsletters

Complex Regional Pain Syndrome Newsletter
Complex Regional Pain Syndrome

A chronic pain condition, Complex Regional Pain Syndrome (CRPS) often affects one limb and is believed to be caused by injury, or malfunction of..

Duchenne Muscular Dystrophy Newsletter
Duchenne Muscular Dystrophy

A genetic disorder, Duchenne Muscular Dystrophy (DMD), is a progressive form of muscular dystrophy with a higher preponderance in males..

Evolution of Precision Medicine in Oncology Whitepaper
Evolution of Precision Medicine in Oncology

Past decades have witnessed a shift in the focus of researchers and pharma companies towards tailoring the treatment approach and..

Fibrodysplasia Ossificans Progressiva Whitepaper
Fibrodysplasia Ossificans Progressiva

Fibrodysplasia Ossificans Progressiva (FOP) is a rare disorder that results in gradual ossification of the connective...

Cancer Globally (Vol. 1, Issue 1) Newsletter
Cancer Globally (Vol. 1, Issue 1)

Cancer has gripped the human society in its clutches in such a way that there has been many advancements to treat the same, but with little success.